Bio Impact Capital LLC Sells in Q3 2024

Bio Impact Capital LLC

  • $641 Million
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
ETNB
89bio, Inc.

Healthcare
-792K
- 70.58%
$7.36 - $9.66 $5.83M - $7.65M
330K $2.44M
RGNX
Regenxbio Inc.

Healthcare
-507K
- 91.02%
$10.49 - $14.39 $5.32M - $7.3M
50K $524K
NTLA
Intellia Therapeutics, Inc.

Healthcare
-176K
- 39.67%
$19.72 - $27.36 $3.47M - $4.81M
268K $5.5M
GH
Guardant Health, Inc.

Healthcare
-830
- 0.17%
$22.3 - $36.29 $18.5K - $30.1K
499K $11.4M
STRO
Sutro Biopharma, Inc.

Healthcare
-211K
- 6.94%
$2.88 - $5.01 $608K - $1.06M
2.83M $9.8M
CRNX
Crinetics Pharmaceuticals, Inc.

Healthcare
-31.3K
- 5.62%
$43.83 - $54.98 $1.37M - $1.72M
526K $26.9M
RARE
Ultragenyx Pharmaceutical Inc.

Healthcare
-50.8K
- 13.35%
$40.21 - $59.36 $2.04M - $3.02M
330K $18.3M
Activity Summary
Buys All Purchases 30 New Holdings 10 Increased Positions 20 Sells All Sells 7 Reductions 7 Sold out 0 Options Calls 0 Puts 0
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email